600 patients66,869 observations120 daysLIVE

Patient P-01877

Synthetic patientNBL-101 · Day 118 · 35–44 · M · baseline S01Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Improving
GI state
Unstable
Inflammatory state
Stable
Nutritional resilience
Unstable
Discontinuation risk
89%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S01
  2. Day 79 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 82 CR-01 recommendedClinician Review CR-01
  4. Day 83 Patient acceptedStarted CR-01 in the companion
  5. Day 88 Deterioration detected before clinical escalationClinician Review CR-01

What changed?

Trajectory began diverging from predicted response on Day 79.

Primary contributors, last 14 days
  • GI instability+24
  • Toxicity-9
  • Nutritional resilience-8
  • Inflammatory activity+4
  • Treatment adherence-3

What helped?

  • Clinician Review CR-01Day 82
    Result: deterioration detected before clinical escalation
LIFE OS recommendation
GI Support Protocol GI-04
63%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 83% showed improvement
  • median effect visible after 8 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden
Companion
71.7/100
stable · +1.7 vs previous 14 d
Toxicity
Blood
44.1/100
improving · -6.3 vs previous 14 d
Sleep quality
Wearable
0.9/100
worsening · -4.2 vs previous 14 d
Energy level
Daily log
2.2/10
improving · +0.3 vs previous 14 d
Stress level
Daily log
6.9/10
stable · -0.1 vs previous 14 d
Steps
Wearable
3,499
worsening · -318 vs previous 14 d
Adherence
Companion
67.5 %
worsening · -13.4 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards failing · 45 from the failing basin, 66 from restoration.

Would help
  • GI-04 GI Support Protocol
    73% improved among 124 similar · onset 8 d · confidence 61%
  • ME-01 Monitoring Escalation
    100% improved among 77 similar · onset 3 d · confidence 71%
  • NP-02 Dietary Support Protocol
    63% improved among 64 similar · onset 10 d · confidence 71%
Would not help
  • Keep simple carbs low
    GI +5.2 next day on high-intake days · n 21
  • Keep alcohol low
    GI +5.1 next day on high-intake days · n 18
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Simple carbohydrates
    +5.2detractor · 95%
  • Alcohol
    +5.1detractor · 95%
  • Insoluble fibre
    -2.5no signal · 50%
  • Spicy / capsaicin
    +2no signal · 30%
  • Histamine load
    -1.1no signal · 21%
  • Dietary fat load
    -0.6no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Inflammatory signalling 65
    • DNAIL6 -174 variant raises baseline inflammatory tone
    • BloodInflammatory load index 58
    • WearableHRV 26 ms, trending down
  • Mucosal barrier integrity 60
    • MicrobiomeAkkermansia low → thinner mucus layer
    • Daily logGI symptom score 72 and rising
    • WearableSleep 4.2 h, below personal baseline
  • Autonomic recovery 40
    • Wearable3,499 steps/day
    • WearableShort sleep window
  • Butyrate / short-chain fatty acid production 20
    • Daily logFibre intake low in recent food logs
  • Drug metabolism and exposure 20
    • BloodToxicity index 44
DNA
Fictional pharmacogenomic panel
  • IL6 -174 G/C
    Higher inflammatory tone
  • CYP2D6 Normal metabolizer
    Expected exposure
  • MTHFR C677T
    Reduced folate turnover
Microbiome
Shannon diversity 2.3 · butyrate capacity 48/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisNormal
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
29 ms
Sleep
5.5 h
Steps
3,616
Resting HR
69 bpm
Daily log: GI score 72, nutritional resilience 35, adherence 68.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • A 15-minute walk after lunch
  • Protect a 7.5-hour sleep window; screens off 30 minutes before
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: oral nutrition supplement with lunch

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0180421%S19AD-05improved61
P-0138841%S17CR-01improved59
P-0183540%S17CR-01improved56
P-0169637%S20CR-01improved59
P-0170837%S07CR-01improved59
P-0137135%S06CR-01improved63
P-0144233%S13CR-01improved61
P-0143021%S05CR-01improved54
P-0134221%S11DT-01improved48
P-0176721%S14DT-01no change63
P-0169940%S04GI-04improved69
P-0172534%S18GI-04no change56